STAT1 and breast cancer: Collectively, these results suggest that the replacement of miR-145 exerts anti-proliferative effects on BC cells through the regulation of the IFN-STAT1/2 pathway and also that the underlying mechanisms appear to be shared between humans and rats (Figure 1I).